Literature DB >> 31810526

Systemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of Asia.

Kazuomi Kario1, Julio A Chirinos2, Raymond R Townsend2, Michael A Weber3, Angelo Scuteri4, Alberto Avolio5, Satoshi Hoshide6, Tomoyuki Kabutoya6, Hirofumi Tomiyama7, Koichi Node8, Mitsuru Ohishi9, Sadayoshi Ito10, Takuya Kishi11, Hiromi Rakugi12, Yan Li13, Chen-Huan Chen14, Jeong Bae Park15, Ji-Guang Wang16.   

Abstract

Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) but the association between HTN and CVD cannot be explained by average blood pressure (BP) alone. BP variability (BPV) is another important factor, along with the effects of HTN on the vasculature. The concept of systemic hemodynamic atherothrombotic syndrome (SHATS) has been proposed, describing an age-related and synergistic vicious cycle of hemodynamic stress and vascular disease. The importance of SHATS is based on the assumption that the assessment of BPV and arterial disease is likely to provide an effective opportunity to intervene early to reduce progression to HTN in younger patients or to CVD events and organ damage in older patients. In addition to providing an overview of current evidence for the mechanisms and clinical data related to SHATS, this article proposes a new SHATS score for use to diagnose and assess the severity of SHATS. The score includes two components - a BP score and a vascular score - which are multiplied to generate the SHATS score. This reflects the synergistic, rather than additive, effects of BP and vascular disease on target organ damage and CVD events. Although it requires refinement and validation in future studies, early detection of SHATS using tools such as the proposed score, combined with population-based stratification and technology-based anticipation medicine incorporating real-time individual data, has the potential to contribute to meaningful reductions in rates of CVD events and target organ damage.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Blood pressure control; Blood pressure variability; Morning hypertension; Nocturnal hypertension; Synergistic resonance; Systemic hemodynamic atherothrombotic syndrome (SHATS)

Year:  2019        PMID: 31810526     DOI: 10.1016/j.pcad.2019.11.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  6 in total

Review 1.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

2.  [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].

Authors:  C Chen; C Chen; J T Yan; N Zhou; J P Zhao; D W Wang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2020-07-24

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26

5.  SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.

Authors:  G Y Oudit; Z Kassiri; C Jiang; P P Liu; S M Poutanen; J M Penninger; J Butany
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686

6.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.

Authors:  Yingxia Liu; Yang Yang; Cong Zhang; Fengming Huang; Fuxiang Wang; Jing Yuan; Zhaoqin Wang; Jinxiu Li; Jianming Li; Cheng Feng; Zheng Zhang; Lifei Wang; Ling Peng; Li Chen; Yuhao Qin; Dandan Zhao; Shuguang Tan; Lu Yin; Jun Xu; Congzhao Zhou; Chengyu Jiang; Lei Liu
Journal:  Sci China Life Sci       Date:  2020-02-09       Impact factor: 6.038

  6 in total
  15 in total

1.  Association between organ damage and visceral adiposity index in community-dwelling elderly Chinese population: the Northern Shanghai Study.

Authors:  Chong Xu; Song Zhao; Shikai Yu; Chen Chi; Ximin Fan; Hongwei Ji; Rusitanmujiang Maimaitiaili; Jiadela Teliewubai; Xiaofeng Li; Yi Zhang; Yawei Xu
Journal:  Aging Clin Exp Res       Date:  2020-11-21       Impact factor: 3.636

2.  Highly precise risk prediction model for new-onset hypertension using artificial intelligence techniques.

Authors:  Hiroshi Kanegae; Kenji Suzuki; Kyohei Fukatani; Tetsuya Ito; Nakahiro Harada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-09       Impact factor: 3.738

3.  Management of Hypertension in the Digital Era: Small Wearable Monitoring Devices for Remote Blood Pressure Monitoring.

Authors:  Kazuomi Kario
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

4.  Oxidized LDL Causes Endothelial Apoptosis by Inhibiting Mitochondrial Fusion and Mitochondria Autophagy.

Authors:  Jia Zheng; Chengzhi Lu
Journal:  Front Cell Dev Biol       Date:  2020-11-11

5.  A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial.

Authors:  Kazuomi Kario; Akihiro Nomura; Noriko Harada; Tomoyuki Tanigawa; Ryuhei So; Kiyose Nakagawa; Shin Suzuki; Ayako Okura; Eisuke Hida; Kohta Satake
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-20       Impact factor: 3.738

6.  Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study.

Authors:  Kazuomi Kario; Kenta Okada; Mitsunobu Murata; Daisuke Suzuki; Kayo Yamagiwa; Yasuhisa Abe; Isao Usui; Norihiro Tsuchiya; Chie Iwashita; Noriko Harada; Yukie Okawara; Shun Ishibashi; Satoshi Hoshide
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

7.  High prevalence of masked uncontrolled morning hypertension in elderly non-valvular atrial fibrillation patients: Home blood pressure substudy of the ANAFIE Registry.

Authors:  Kazuomi Kario; Naoyuki Hasebe; Ken Okumura; Takeshi Yamashita; Masaharu Akao; Hirotsugu Atarashi; Takanori Ikeda; Yukihiro Koretsune; Wataru Shimizu; Hiroyuki Tsutsui; Kazunori Toyoda; Atsushi Hirayama; Masahiro Yasaka; Takenori Yamaguchi; Satoshi Teramukai; Tetsuya Kimura; Jumpei Kaburagi; Atsushi Takita; Hiroshi Inoue
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-15       Impact factor: 3.738

8.  Stress-Induced Blood Pressure Elevation Self-Measured by a Wearable Watch-Type Device.

Authors:  Naoko Tomitani; Hiroshi Kanegae; Yuka Suzuki; Mitsuo Kuwabara; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2021-04-20       Impact factor: 2.689

9.  The effects of foot reflexology on blood pressure and heart rate: A randomized clinical trial in stage-2 hypertensive patients.

Authors:  Praew Kotruchin; Supap Imoun; Thapanawong Mitsungnern; Patcharin Aountrai; Maneenuch Domthaisong; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-15       Impact factor: 3.738

Review 10.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.